-
Signature
-
/s/ Raymond Bussiere as authorized signatory for Paul J. Brody
-
Issuer symbol
-
IBKR
-
Transactions as of
-
15 Sep 2025
-
Transactions value $
-
-$12,252,246
-
Form type
-
4
-
Filing time
-
17 Sep 2025, 16:04:22 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Brody Paul Jonathan |
Chief Financial Officer, Director |
ONE PICKWICK PLAZA, GREENWICH |
/s/ Raymond Bussiere as authorized signatory for Paul J. Brody |
17 Sep 2025 |
0001391403 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
IBKR |
Class A common stock |
Sale |
-$3.59M |
-57.3K |
-9.91% |
$62.66 |
521K |
15 Sep 2025 |
by PJB Holdings LLC |
F1, F2 |
| transaction |
IBKR |
Class A common stock |
Sale |
-$2.39M |
-37.5K |
-7.21% |
$63.79 |
483K |
15 Sep 2025 |
by PJB Holdings LLC |
F1, F3 |
| transaction |
IBKR |
Class A common stock |
Sale |
-$96.3K |
-1.5K |
-0.31% |
$64.26 |
482K |
15 Sep 2025 |
by PJB Holdings LLC |
F1, F4 |
| transaction |
IBKR |
Class A common stock |
Sale |
-$6.14M |
-98.6K |
-20.48% |
$62.24 |
383K |
16 Sep 2025 |
by PJB Holdings LLC |
F1, F5 |
| transaction |
IBKR |
Class A common stock |
Sale |
-$36.8K |
-587 |
-0.15% |
$62.62 |
382K |
16 Sep 2025 |
by PJB Holdings LLC |
F1, F6 |
| holding |
IBKR |
Class A common stock |
|
|
|
|
|
2.89M |
15 Sep 2025 |
Direct |
F7 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: